Balentine LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,745
| Closed | -$855K | – | 205 |
|
|
2025
Q1 | $855K | Buy |
2,745
+1,950
| +245% | +$576K | 0.04% | 77 |
|
|
2024
Q4 | $207K | Sell |
795
-35
| -4% | -$10.4K | 0.01% | 137 |
|
|
2024
Q3 | $267K | Buy |
830
+3
| +0.4% | +$981 | 0.01% | 138 |
|
|
2024
Q2 | $258K | Sell |
827
-7,525
| -90% | -$2.21M | 0.01% | 108 |
|
|
2024
Q1 | $2.37M | Buy |
8,352
+557
| +7% | +$163K | 0.07% | 92 |
|
|
2023
Q4 | $2.25M | Buy |
7,795
+1,723
| +28% | +$469K | 0.07% | 92 |
|
|
2023
Q3 | $1.63M | Buy |
6,072
+1,398
| +30% | +$349K | 0.05% | 103 |
|
|
2023
Q2 | $1.04M | Sell |
4,674
-313
| -6% | -$72.6K | 0.03% | 149 |
|
|
2023
Q1 | $1.21M | Sell |
4,987
-1,859
| -27% | -$456K | 0.04% | 141 |
|
|
2022
Q4 | $1.8M | Buy |
6,846
+98
| +1% | +$26.3K | 0.06% | 115 |
|
|
2022
Q3 | $1.52M | Buy |
6,748
+454
| +7% | +$110K | 0.06% | 112 |
|
|
2022
Q2 | $1.53M | Buy |
6,294
+1,897
| +43% | +$465K | 0.06% | 143 |
|
|
2022
Q1 | $1.06M | Buy |
4,397
+1,829
| +71% | +$420K | 0.04% | 159 |
|
|
2021
Q4 | $578K | Buy |
2,568
+1,246
| +94% | +$263K | 0.02% | 150 |
|
|
2021
Q3 | $281K | Sell |
1,322
-18
| -1% | -$4.14K | 0.01% | 190 |
|
|
2021
Q2 | $327K | Sell |
1,340
-421
| -24% | -$104K | 0.01% | 110 |
|
|
2021
Q1 | $438K | Buy |
1,761
+260
| +17% | +$62K | 0.02% | 81 |
|
|
2020
Q4 | $345K | Buy |
1,501
+29
| +2% | +$6.69K | 0.02% | 96 |
|
|
2020
Q3 | $374K | Buy |
1,472
+152
| +12% | +$37.7K | 0.02% | 77 |
|
|
2020
Q2 | $311K | Buy |
1,320
+745
| +130% | +$170K | 0.02% | 65 |
|
|
2020
Q1 | $117K | Sell |
575
-439
| -43% | -$95.9K | 0.01% | 125 |
|
|
2019
Q4 | $244K | Buy |
1,014
+833
| +460% | +$184K | 0.01% | 64 |
|
|
2019
Q3 | $35K | Buy |
181
+48
| +36% | +$9.21K | ﹤0.01% | 170 |
|
|
2019
Q2 | $25K | Buy |
133
+67
| +102% | +$12K | ﹤0.01% | 182 |
|
|
2019
Q1 | $13K | Sell |
66
-53
| -45% | -$10.1K | ﹤0.01% | 238 |
|
|
2018
Q4 | $23K | Hold |
119
| – | – | ﹤0.01% | 177 |
|
|
2018
Q3 | $25K | Buy |
+119
| New | +$23.5K | ﹤0.01% | 118 |
|
|
2018
Q1 | – | Sell |
-1,202
| Closed | -$209K | – | 83 |
|
|
2017
Q4 | $209K | Buy |
1,202
+116
| +11% | +$20.5K | 0.02% | 118 |
|
|
2017
Q3 | $202K | Buy |
1,086
+304
| +39% | +$53.9K | 0.02% | 118 |
|
|
2017
Q2 | $135K | Hold |
782
| – | – | 0.01% | 133 |
|
|
2017
Q1 | $128K | Hold |
782
| – | – | 0.01% | 136 |
|
|
2016
Q4 | $114K | Buy |
782
+14
| +2% | +$2.11K | 0.01% | 136 |
|
|
2016
Q3 | $128K | Sell |
768
-12
| -2% | -$2.03K | 0.02% | 106 |
|
|
2016
Q2 | $119K | Hold |
780
| – | – | 0.02% | 101 |
|
|
2016
Q1 | $117K | Sell |
780
-348
| -31% | -$51.7K | 0.03% | 76 |
|
|
2015
Q4 | $183K | Buy |
1,128
+330
| +41% | +$51.9K | 0.04% | 78 |
|
|
2015
Q3 | $110K | Buy |
798
+511
| +178% | +$80.5K | 0.02% | 90 |
|
|
2015
Q2 | $44K | Sell |
287
-70
| -20% | -$11.2K | 0.01% | 158 |
|
|
2015
Q1 | $57K | Buy |
+357
| New | +$56.2K | 0.01% | 129 |
|
Other funds holding AMGN
Balentine LLC's AMGN Position: Q2 2025 in Review
Balentine LLC sold out of Amgen (AMGN) in Q2 2025, closing a stake of 2,745 shares — an estimated $855K sold.
Balentine LLC first reported a position in AMGN in Q1 2015 and held it in 39 quarters. The position peaked at $2.37M in Q1 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- Balentine LLC reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
- Balentine LLC sold 2,745 Amgen shares in Q2 2025, an estimated $855K.
- Balentine LLC first reported a position in Amgen in Q1 2015 and held it in 39 quarters.
- Balentine LLC's Amgen position peaked at $2.37M in Q1 2024.
- 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on Balentine LLC's 13F filing for Q2 2025, filed 4 Aug 2025.